Per-Olof Berggren, Ph.D., is Professor and Head Cell Biology and Experimental Endocrinology, Department of Molecular Medicine and Surgery, Director The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Stockholm, Sweden since 1997. Visiting Research Professor, Mary Lou Held Professor of Diabetes Research, Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL, USA since 2002. Visiting Professor, Division of Integrative Biosciences and Biotechnology, University of Science and Technology, Pohang, South Korea since 2010. Visiting Professor, Lee Kong Chian School of Medicine/Nanyang Technological University, Singapore since 2012. Senior Consultant, Singapore Eye Research Institute, Singapore since 2013. Senior Research Investigator, Department of Medicine, Faculty of Medicine, Imperial College, London, UK 2012-2020. Distinguished Professor at the University of Rome Tor Vergata, Italy since 2016. Visiting Professor, West China Hospital of Sichuan University Chengdu, China since 2019. Visiting Professor, University of Ulster, Coleraine, Northern Ireland since 2020. Visiting Professor, TecSalud Tecnológico de Monterrey, Mexico since 2021.
Professor Berggren is a world-leader within the field of pancreatic islet research. He has done pioneering work regarding the fundamental mechanisms regulating the stimulus-response coupling in the endocrine pancreas with several seminal contributions within the fields of insulin secreting pancreatic β-cell Ca2+ handling, phosphorylated inositol compounds and insulin receptor operated signaling. In addition to developing novel concepts within the field of β-cell stimulus-secretion coupling regulation, Professor Berggren’s research is characterized by a number of important methodological innovations.
He recently developed an elegant and versatile in vivo experimental platform using the anterior chamber of the eye as a transplantation site and the cornea as a natural body window for imaging. This not only allows non-invasive and longitudinal studies of pancreatic β-cell function and survival at single cell resolution but may also have clinical implications for the treatment of diabetes.
Professor Berggren is member of Academia Europaea, the Royal Swedish Academy of Sciences, the Nobel Assembly at Karolinska Institutet, EMBO, the National Academy of Medicine (USA), the American Academy of Arts and Sciences and the Korean Academy of Science and Technology.